The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques

Inflammopharmacology

Volumn 19, Issue 2, 2011, Pages 55-68

  Ahmadzai, Hasib ^a,b   Wakefield, Denis ^a,c   Thomas, Paul S ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c ST VINCENT'S CLINIC   (Australia)

Author keywords

Exhaled breath condensate; Flow cytometry; Inflammatory markers; Kveim Siltzbach test; Sarcoidosis; T H1 T H2 balance; T H17 cytokine measurement

Indexed keywords

CHEMOKINE; CHITOTRIOSIDASE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; LYMPHOTOXIN; LYSOZYME; MACROPHAGE MIGRATION INHIBITION FACTOR; NEOPTERIN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

DIAGNOSTIC TEST; DISEASE MARKER; EXHALED BREATH CONDENSATE; GENETIC PREDISPOSITION; GENETIC RISK; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNOPATHOGENESIS; KVEIM SILTZBACH TEST; KVEIM TEST; LUNG LAVAGE; LUNG SARCOIDOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS; REVIEW; SARCOIDOSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

BIOLOGICAL MARKERS; BREATH TESTS; CYTOKINES; HUMANS; MONITORING, IMMUNOLOGIC; SARCOIDOSIS;

EID: 79958210818     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-011-0079-3     Document Type: Review

References (164)

1. Agostini C, Adami F, Semenzato G (2000) New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 12:71-76
2. Agostini C, Meneghin A, Semenzato G (2002) T-lymphocytes and cytokines in sarcoidosis. Curr Opin Pulm Med 8(5):435-440
3. Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, Nakashima K, Matsuda A, Kanda M, Enomoto T, Ohno S, Nakashima H, Casanova J, Hopkin JM, Tamari M, Mao X, Shirakawa T (2004) Association between IFNA genotype and the risk of sarcoidosis. Hum Genet 114:503-509
4. Allen RK, Pierce RJ, Barter CE (1992) Angiotensin-converting enzyme in bronchoalveolar lavage fluid in sarcoidosis. Sarcoidosis 9(1):54-59
5. Allen SS, Evans W, Carlisle J, Hajizadeh R, Nadaf M, Shepherd BE, Pride DT, Johnson JE, Drake WP (2008) Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses. Respir Res 9:36-47
6. Antoniou KM, Soufla G, Proklou A, Margaritopoulos G, Choulaki C, Lymbouridou R, Samara KD, Spandidos DA, Siafakas NM (2009) Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol 537929 (Epub 2010 Feb 14)
7. Bargagli E, Mazzi A, Rottoli P (2008) Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med 29(3):445-458
8. Baughman RP, Lower EE, du Bois RM (2003) Sarcoidosis. Lancet 361:1111-1118
9. Beirne P, Pantelidis P, Charles P, Wells AU, Abraham DJ, Denton CP, Welsh KI, Shah PL, du Bois RM, Kelleher P (2009) Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur Respir J 34(6):1376-1382
10. Berge BT, Paats MS, Bergen IM, van den Blink B, Hoogsteden HC, Lambrecht BN, Hendriks RW, KleinJan A (2010) IL-17 and IL-22 expressing cells are involved in granuloma pathogenesis in pulmonary sarcoidosis. Am J Respir Crit Care Med 181(1):A3983
11. H17 cells. Nature 453:1051-1057
12. Biller H, Ruprecht B, Gaede KI, Müller-Quernheim J, Zissel G (2009) Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 26(2):139-146
13. Bolukbas C, Bolukbas FF, Kebdir T, Canayaz L, Dalay AR, Kilic G, Ovunc O (2005) Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - a case report and review of the literature. Acta gastroenterel Belg 68(4):432-434
14. Brice EA, Friedlander W, Bateman ED, Kirsch RE (1995) Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD. Chest 107(3):706-710
15. Brown ST, Brett I, Almenoff PL, Lesser M, Terrin M, Teirstein AS (2003) Recovery of cell wall-deficient organisms does not distinguish between patients with sarcoidosis and control subjects. Chest 123:413-417
16. Cannone M, Vago L, Porini G, Bonetto S, Cassi C, Bramerio M, Rizzato G, Barberis MC (1997) Detection of Mycobacterium tuberculosis DNA using nested polymerase chain reaction in lymph nodes with sarcoidosis, fixed in formalin and embedded in paraffin. Pathologica 89(5):512-516
17. Carlisle J, Evans W, Hajizadeh R, Nadaf M, Shepherd B, Ott RD, Richter K, Drake WP (2007) Multiple Mycobacterium antigens induce interferon-γ production for sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol 150:460-468
18. Celik G, Sen E, Ulger AF, Kumbasar OO, Bozkaya H, Alper D, Karayalcin S (2005) Sarcoidosis caused by interferon therapy. Respirology 10(4):535-540
19. Chan HP, Lewis C, Thomas PS (2008) Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 63:164-168
20. Chase MW (1961) The preparation and standardization of Kveim testing antigen. Am Rev Respir Dis 84(5):Pt. 2:86-88
21. Chase MW, Siltzbach LE (1967) Concentration of the active principle responsible for the Kveim reaction. In: Proceedings of the 4th international conference on sarcoidosis, Mason, Paris
22. Chen ES, Moller DR (2006) Cytokines and chemokines in sarcoidosis. Lung biology in health and disease - sarcoidosis, vol 210. Taylor and Francis Group, New York
23. Chen ES, Moller DR (2008) Etiology of sarcoidosis. Clin Chest Med 29:365-377
24. Chen ES, Wahlström J, Song Z, Willett MH, Wikén M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, Grunewald J, Moller DR (2008) T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 181:8784-8796
25. Chen ES, Song Z, Willett MH, Heine S, Yung RC, Liu MC, Groshong SD, Zhang Y, Tuder RM, Moller DR (2010) Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med 181:360-373
26. Chow S (2009) Non-invasive measurement of markers of oxidative stress in asbestos-related lung diseases and pulmonary fibrosis. PhD thesis, Department of Pathology, University of New South Wales, Sydney
27. Cowling DC, Quaglino D, Barrett PKM (1964) Effect of Kveim antigen and old tuberculin on lymphocytes in culture from sarcoid patients. Br Med J 1(5396):1481-1482
28. Crystal R (2005) Sarcoidosis. Harrison's principles of internal medicine. McGraw-Hill, New York
29. Cummings MM (1964) An evaluation of the possible relationship of pine pollen to sarcoidosis (a critical summary). Acta Medica Scand 425(Supp):48-50
30. de Silva RN, Will RG (1993) Moratorium on Kveim test. Lancet 342(8864):173
31. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ (2002) Molecular analysis of sarcoidosis tissues for Mycobacterium species DNA. Emerg Infect Dis 8(11):1334-1341
32. Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, Newman LS, Kalams SA (2007) Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 75(1):527-530
33. Dubaniewicz A (2010) Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun Rev 9(6):419-424
34. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, Mýsliwski A (2007) Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 12:346-354
35. Edmé JL, Tellart AS, Launay D, Neviere R, Grutzmacher C, Boulenguez C, Labalette M, Hachulla E, Hatron PY, Dessaint JP, Matran R, Sobaszek A (2008) Cytokine concentrations in exhaled breath condensates in systemic sclerosis. Inflamm Res 57(4):151-156
36. Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T, Takizawa T, Koike M, Kudoh S, Costabel U, Guzman J, Rizzato G, Gambacorta M, du Bois R, Nicholson AG, Sharma OP, Ando M (2002) Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40(1):198-204
37. Eklund A, Blaschke E (1986) Elevated serum neopterin levels in sarcoidosis. Lung 164(6):325-332
38. Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, Semenzato G, Agostini C (2010) Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax December 7 2010 (Epub ahead of print)
39. Faehling M, Anders D, Hetzel M, Hombach V, Bachem M (2008) HGF and IL-6 in BAL fluid of interstitial lung diseases: effect on human lung fibroblasts. Eur Respir J Suppl 32(Supp 52):316S
40. Foulon G, Wislez M, Naccache JM, Blanc FX, Rabbat A, Israël-Biet D, Valeyre D, Mayaud C, Cadranel J (2004) Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 38(3):418-425
41. Gazouli M, Ikonomopoulos J, Trigidou R, Foteinou M, Kittas C, Gorgoulis V (2002) Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 40:3060-3063
42. Gerke AK, Hunninghake G (2008) The immunology of sarcoidosis. Clin Chest Med 29(3):379-390
43. Gronhagen-Riska C, Kurppa K, Fyhrquist F, Selroos O (1978) Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. Scand J Respir Dis 59(4):228-231
44. Grosser M, Luther T, Muller J, Schuppler M, Brickhardt J, Matthiessen W, Muller M (1999) Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response. Lab Investig J Tech Methods Pathol 79(7):775-784
45. Grunewald J, Eklund A (2007) Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 4(5):461-464
46. Grunewald J, Wahlström J, Berlin M, Wigzell H, Eklund A, Olerup O (2002) Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation. Thorax 57:348-352
47. Grunewald J, Brynedal B, Darlington P, Nisell M, Cederlund K, Hillert J, Eklund A (2010) Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res 11:25-31
48. Gupta SK, Chakraborty M, Mitra K (1992) Serum angiotensin converting enzyme in respiratory diseases. Indian J Chest Dis Allied Sci 34(1):19-24
49. Gupta D, Agarwal R, Agarwal AN, Jindal SK (2007) Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 30(3):508-516
50. Gurrieri C, Bortoli M, Brunetta E, Piazza F, Agostini C (2005) Cytokines, chemokines and other biomolecular markers in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22(Supp 1):S9-S14
51. Hajizadeh R, Sato H, Carlisle J, Nadaf MT, Evans W, Shepherd BE, Miller RF, Kalams SA, Drake WP (2007) Mycobacterium tuberculosis antigen 85A induces Th-1 immune responses in systemic sarcoidosis. J Clin Immunol 27(4):445-454
52. Hauber H, Gholami D, Meyer A, Pforte A (2003) Increased interleukin-13 expression in patients with sarcoidosis. Thorax 58(6):519-524
53. Hill TA, Lightman S, Pantelidis P, Abdallah A, Spagnolo P, du Bois RM (2008) Intracellular cytokine profiles and T cell activation in pulmonary sarcoidosis. Cytokine 42:289-292
54. Homolka J, Lorenz J, Zuchold HD, Müller-Quernheim J (1992) Evaluation of soluble CD 14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis. Clin Investig 70(10):909-916
55. Hörster R, Kirsten D, Gaede KI, Jafari C, Strassburg A, Greinert U, Kalsdorf B, Ernst M, Lange C (2009) Antimycobacterial immune responses in patients with pulmonary sarcoidosis. Clin Respir J 3(4):229-238
56. Horváth I, Hunt J, Barnes PJ (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26(3):523-548
57. Horváth I, Lázár Z, Gyulai N, Kollai M, Losonczy G (2009) Exhaled biomarkers in lung cancer. Eur Respir J 34(1):261-275
58. Husain AN (2010) The lung. In: Kumar V, Abbas AK, Fausto N, Aster JC (eds) Robbins and Cotran Pathologic basis of disease, 8th edn. Elsevier Saunders, Philadelphia
59. Iannuzzi MC, Maliarik M, Poisson LM, Rybicki BA (2003) Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 167:1225-1231
60. Iannuzzi MC, Maliarik M, Rybicki BA (2006) Genetics of sarcoidosis. lung biology in health and disease - sarcoidosis, vol 210. Taylor and Francis Group, New York
61. Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357(21):2153-2165
62. Idali F, Wikén M, Wahlstrom J, Mellstedt H, Eklund A, Rabbani H, Grunewald J (2006) Reduced Th1 response in the lungs of HLA-DRB1* 0301 patients with pulmonary sarcoidosis. Eur Respir J 27:451-459
63. Iida KKJ, Kawakami K, Matsubara Y, Shirai R, Kohno S (1997) Analysis of T cell subsets and β chemokines in patients with pulmonary sarcoidosis. Thorax 52:431-437
64. C2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis. J Allergy Clin Immunol 107(2):337-344
65. Ishige I, Eishi Y, Takemura T, Kobayashi I, Nakata K, Tanaka I, Nagaoka S, Iwai K, Watanabe K, Takizawa T, Koike M (2005) Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22(1):33-42
66. Izumi T, Nilsson BS, Ripe E (1973) In vitro lymphocyte reactivity to different Kveim preparations in patients with sarcoidosis. Scand J Respir Dis 54(2):123-127
67. Jackson AS, Sandrini A, Campbell C, Chow S, Thomas PS, Yates DH (2007) Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 175:222-227
68. Jamaati H, Mansoori S, Najafizadeh K, Mohammadi F, Masjedi M, Entezami Z, Shahgasempour S (2003) T-lymphocyte subsets in bronchoalveolar lavage: a flow cytometric analysis and its importance in the differential diagnosis of sarcoidosis. Arch Iran Med 6(3):204-207
69. James GD, Williams WJ (1991) Kveim-Siltzbach test revisited. Sarcoidosis 8(1):6-9
70. Kataria YP (2006) 8. The Kveim-Siltzbach skin test. Lung biology in health and disease - sarcoidosis, vol 210. Taylor and Francis Group, New York
71. Katchar K, Wahlström J, Eklund A, Grunewald J (2001) Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med 163(7):1540-1545
72. Katchar K, Eklund A, Grunewald J (2003) Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 254:564-571
73. Kharitonov SA, Barnes PJ (2001) Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163:1693-1722
74. Klein JT, Horn TD, Forman JD, Silver RF, Teirstein AS, Moller DR (1995) Selection of oligoclonal Vβ-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol 154:1450-1460
75. Klemen H, Husain AN, Cagle PT, Garrity ER, Popper HH (2000) Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung - a PCR-based study on four cases. Virchows Arch 436(4):365-369
76. Kon OM, du Bois RM (1997) Mycobacteria and sarcoidosis. Thorax 52(Suppl 3):S47-S51
77. Kowalska A, Puścińska E, Czerniawska J, Goljan-Geremek A, Czystowska M, Roży A, Chorostowska-Wynimko J, Górecka D (2010) Markers of fibrosis and inflammation in exhaled breathcondensate (EBC) and bronchoalveolar lavage fluid (BALF) of patients with pulmonary sarcoidosis- a pilot study. Pneumonol Alergol Pol 78(5):356-362 (Polish)
78. Krawczyk A (2006) Immunopathogenesis of sarcoidosis. Int Rev Allergol Clin Immunol 12(2):80-84
79. Kreiss K, Newman LS, Mroz MM, Campbell PA (1989) Screening blood test identifies subclinical beryllium disease. J Occup Med 31(7):603-608
80. Kruit A, Grutters JC, Ruven HJT, van Moorsel CHM, Weiskirchen R, Mengsteab S, van den Bosch JMM (2006) Transforming growth factor-β gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 129:1584-1591
81. Kunisawa A, Kawanishi Y, Tago H, Nagate A, Kasuga I, Ohyashiki K (2002) Direct demonstration of the productive capability of cytokines at the single cell level in lung sarcoidosis using multicolour cytometry. Respiration 69:155-164
82. Kurti V, Mankiewicz E (1972) In vitro study of macrophages from patients with sarcoidosis. Can Med Assoc J 107(6):509-515
83. Kveim A (1941) En ny og spesifikk kutan-reaksjon ved Boeck's sarcoid. Nordisk Medicin 9:169-172
84. Kwiatkowska S, Luczynska M, Grzelewska-Rzymowska I, Nowak D, Zieba M (2005) Comparison of oxidative stress markers in exhaled breath condensate and in serum of patients with tuberculosis and sarcoidosis. Polski Merkuriusz Lekarski 19(109):37-40 (Polish)
85. Lazarus A (2009) Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Month 55:649-660
86. Lebbe C, Agbalika F, Flageul B, Pellet C, Rybojad M, Cordoliani F, Farge D, Vignon-Pennamen MD, Sheldon J, Morel P, Calvo F, Schulz TF (1999) No evidence for the role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis. Br J Dermatol 141:492-496
87. Lenner R, Bregman Z, Teirstein AS, DePalo L (2001) Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy. Chest 119(3):978-981
88. Li N, Bajoghli A, Kubba A, Bhawan J (1999) Identification of mycobacterial DNA in cutaneous lesions in sarcoidosis. J Cutan Pathol 26:271-278
89. Li Y, Wollnik B, Pabst S, Lennarz M, Rohmann E, Gillissen A, Vetter H, Grohé C (2006) BTNL2 gene variant and sarcoidosis. Thorax 61:273-274
90. Lieberman J, Beutler E (1976) Elevation of serum angiotensin-converting enzyme in Gaucher's disease. N Engl J Med 294(26):1442-1444
91. Lien E, Ingalls R (2002) Toll-like receptors. Crit Care Med 30 (1 Supp):S1-S11
92. Lindahl M, Andersson O, Ripe E, Holm G (1988) Stimulation of bronchoalveolar (BAL) and blood lymphocytes by Kveim antigen, tuberculin, and concanavalin A in sarcoidosis. Br Dis Chest 82(4):386-393
93. Lisby G, Milman N, Jacobsen GK (1993) Search for Mycobacterium paratuberculosis DNA in tissue from patients with sarcoidosis by enzymatic gene amplification. Acta Pathol Microbiol Immunol Scand 101(11):876-878
94. Lyons DJ, Mitchell EB, Mitchell DN (1991) Sarcoidosis: in search of Kveim reactivity in vitro. Biomed Pharmacother 45(4-5):187-192
95. Lyons DJ, Donald S, Mitchell DN, Asherson GL (1992) Chemical inactivation of the Kveim reagent. Respiration 59:22-26
96. Martinetti M, Luisetti M, Cuccia M (2002) HLA and sarcoidosis: new pathogenetic insights. Sarcoidosis Vasc Diffuse Lung Dis 19(2):83-95
97. Mathew S, Bauer KL, Fischoeder A, Bhardwaj N, Oliver SJ (2008) The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol 181:746-755
98. McGuire-Gray C, Sinha R, Iyengar S, Millard C, Rybicki BA, Elston RC, Iannuzzi MC (2006) Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet 120(3):420-430
99. Medica I, Kastrin A, Maver A, Peterlin B (2007) Role of genetic polymorphisms in ACE and TNF-a gene in sarcoidosis: a meta-analysis. J Hum Genet 52(10):836-847
100. Meloni F, Solari N, Cavagna L, Morosini M, Montecucco CM, Fietta AM (2009) Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clin Exp Rheumatol 27(5):765-772
101. Milman N (2006) From mycobacteria to sarcoidosis - is the gate still open? Respiration 73:14-15
102. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Kambouchner M, Valeyre D, Chapelon-Abric C, Piette Debré J, Gorochov G (2006) The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203(2):359-370
103. Moller DR (1999) Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16(1):24-31
104. Moller DR (2003) Pulmonary fibrosis of sarcoidosis: new approaches, old ideas. Am J Respir Cell Mol Biol 29:S37-S41
105. Möllers M, Aries SP, Drömann D, Mascher B, Braun J, Dalhoff K (2001) Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 56:487-493
106. Montuschi P, Barnes PJ (2002) Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 23(5):232-237
107. Müller-Quernheim J (1998) Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 12:716-738
108. Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I (2001) Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 164:731-737
109. Nayeri F, Millinger E, Nilsson I, Zetterström Brudin L, Forsberg P (2002) Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med 96(2):115-119
110. Newman LS, Orton R, Kreiss K (1992) Serum angiotensin converting enzyme activity in chronic beryllium disease. Am Rev Respir Dis 146(1):39-42
111. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, Knatterud GL, Thompson BW, Teirstein AS, Yeager H Jr, Johns CJ, Rabin DL, Rybicki BA, Cherniack R, ACCESS Research Group (2004) A case control etiologic study of sarcoidosis - environmental and occupational risk factors. Am J Respir Crit Care Med 170:1324-1330
112. Noor A, Knox KS (2007) Immunopathogenesis of sarcoidosis. Clin Dermatol 25:250-258
113. Nureki S, Miyazaki E, Ando M, Ueno T, Fukami T, Kumamoto T, Sugisaki K, Tsuda T (2008) Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis. Respir Med 102:239-247
114. Oswald-Richter K, Culver DA, Hawkins C, Hajizadeh R, Abraham S, Shepherd BE, Jenkins CA, Judson MA, Drake WP (2009) Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun 77(9):3740-3748
115. Oswald-Richter K, Sato H, Hajizadeh R, Shepherd BE, Sidney J, Sette A, Newman LS, Drake WP (2010) Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. J Clin Immunol 30:157-166
116. Ota M, Amakawa R, Uehira K, Ito T, Yagi Y, Oshiro A, Date Y, Oyaizu H, Shigeki T, Ozaki Y, Yamaguchi K, Uemura Y, Yonezu S, Fukuhara S (2004) Involvement of dendritic cells in sarcoidosis. Thorax 59:408-413
117. Parrish S, Turner JF (2009) Diagnosis of sarcoidosis. Dis Month 55(11):693-703
118. Petrek M, Gibejova A, Drabek J, Mrazek F, Kolek V, Weigl E, du Bois RM (2002) CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis. Immunol Lett 80(3):189-193
119. Petrek M, Kriegova E, Fillerova R, Arakelyan A, Mrazek F, Hutyrova B, Kolek V, du Bois RM (2009) Chemokine network in pulmonary sarcoidosis. Am J Respir Crit Care Med 179(1):A3186
120. Piotrowski WJ, Antczak A, Marczak J, Nawrocka A, Kurmanowska Z, Górski P (2007) Eicosanoids in exhaled breath condensate and BAL fluid of patients with sarcoidosis. Chest 132:589-596
121. Piotrowski WJ, Kurmanowska Z, Antczak A, Marczak J, Górski P (2010a) Exhaled 8-isoprostane as a prognostic marker in sarcoidois. A short-term follow-up. BMC Pulm Med 10:23-29
122. Piotrowski WJ, Kurmanowska Z, Antczak A, Marczak J, Górski P (2010b) Hepatocyte growth factor in exhaled breath and BAL fluid in sarcoidosis. Pneumonol Alergol Pol 78(3):187-191
123. Planck A, Katchar K, Eklund A, Gripenback S, Grunenwald J (2003) T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 20:110-117
124. Prasse A, Georges CG, Biller H, Hamm H, Matthys H, Luttmann W, Virchow JC Jr (2000) Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 122:241-248
125. Psathakis K, Papatheodorou G, Plataki M, Panagou P, Loukides S, Siafakas NM, Bouros D (2004) 8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest 125:1005-1011
126. Robinson BW, McLemore TL, Crystal RG (1985) Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Investig 75(5):1488-1495
127. Robroeks CM, Rijkers GT, Jöbsis Q, Hendriks HJ, Damoiseaux JG, Zimmermann LJ, van Schayck OP, Dompeling E (2010) Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clin Exp Allergy 40(1):77-84
128. Rossman MD, Kreider ME (2003) Is chronic beryllium disease sarcoidosis of known etiology? Sarcoidosis Vasc Diffuse Lung Dis 20:104-109
129. Rottoli P, Magi B, Perari MG, Liberatori S, Nikiforakis N, Bargagli E, Cianti R, Bini L, Pallini V (2005) Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 5:1423-1430
130. Rożyi ACJ, Stȩpniewska A, Woźbińska B, Goljan A, Puścińska E, Górecka D, Chorostowska-Wynimko J (2006) Inflammatory markers in the exhaled breath condensate of patients with pulmonary sarcoidosis. J Physiol Pharmacol 57(4):335-340
131. Rybicki BA, Maliarik MJ, Major M, Popovich J Jr, Iannuzzi MC (1997) Genetics of sarcoidosis. Clin Chest Med 18:707-717
132. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC (2005) The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet 77(3):491-499
133. Saboor SA, Johnson NM, McFadden J (1992) Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 339:1012-1015
134. 1 in sarcoidosis. Eur Respir J 12:913-919
135. Sato H, Grutters JC, Pantelidis P, Mizzon AN, Ahmad T, Van Houte AJ, Lammers JW, Van Den Bosch JM, Welsh KI, Du Bois RM (2002) HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 27(4):406-412
136. Schürmann M, Kwiatkowski R, Albrecht M, Fischer A, Hampe J, Müller-Quernheim J, Schwinger E, Schreiber S (2008) Study of Toll-like receptor gene loci in sarcoidosis. Clin Exp Immunol 152:413-431
137. Semenzato G (2005) ACCESS: a case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22(2):83-86
138. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ (2002) Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 165(9):1290-1293
139. Siltzbach LE (1961) The Kveim test in sarcoidosis: a study of 750 patients. J Am Med Assoc 178:476-482
140. Siltzbach LE (1967) An international Kveim test study in sarcoidosis. In: Proceedings of the fourth international conference on sarcoidosis, Mason, Paris
141. Smallridge RC, Rogers J, Verma PS (1983) Serum angiotensin-converting enzyme: alterations in hyperthyroidism, hypothyroidism and subacute thyroiditis. J Am Med Assoc 250:2489-2493
142. Smith G, Brownell I, Sanchez M, Prystowski S (2008) Advances in the genetics of sarcoidosis. Clin Genet 73:401-412
143. Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR (2005) Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 201(5):755-767
144. Spagnalo P, Sato H, Grunewald J, Brynedal B, Hillert J, Mana J, Wells AU, Eklund A, Welsh KI, du Bois RM (2008) A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*-0301 are independent genetic risk factors for Löfgren's syndrome. J Intern Med 264(5):433-441
145. Takeuchi M, Oh-i K, Suzuki J, Hattori T, Takeuchi A, Okunuki Y, Usui Y, Usui M (2006) Elevated serum levels of CXCL9/monokine induced by interferon-γ and CXCL10/interferon-γ-inducible protein 10 in ocular sarcoidosis. Investig Ophthalmol Vis Sci 47(3):1063-1068
146. Teirstein AS (1986) The Kveim-Siltzbach test. Clin Dermatol 4(4):154-164
147. Thomas KW, Hunninghake GW (2006) Sarcoidosis: the search for a potential pathogen. Lung biology in health and disease - sarcoidosis, vol 210. Taylor and Francis Group, New York
148. Tsiligianni I, Antoniou KM, Kyriakou D, Tzanakis N, Chrysofakis G, Siafakas NM, Bouros D (2005) Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med 5:8-13
149. Uhlar CM, Whitehead AS (1999) Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265:501-523
150. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, Nagy M, Gaede KI, Franke A, Haesler R, Koch A, Lengauer T, Seegert D, Reiling N, Ehlers S, Schwinger E, Platzer M, Krawczak M, Müller-Quernheim J, Schürmann M, Schreiber S (2005) Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37(4):357-364
151. Vokurka M, Lecoissier D, du Bois RM, Wallaert B, Kambouchner M, Tazi A, Hance AJ (1997) Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med 156:1000-1003
152. Voorter CE, Drent M, van den Berg-Loonen EM (2005) Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602- DRB1*150101. Hum Immunol 66:826-835
153. Wahlström J, Berlin M, Sköld CM, Wigzell H, Eklund A, Grunewald J (1999) Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 54:339-346
154. Wahlström J, Katchar K, Wigzell H, Olerup O, Eklund A, Grunewald J (2001) Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 163:115-121
155. Wahlström J, Dengjel J, Persson B, Duyar H, Rammensee HG, Stevanović S, Eklund A, Weissert R, Grunewald J (2007) Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 117(11):3576-3582
156. Wahlström J, Dengjel J, Winqvist O, Targoff I, Persson B, Duyar H, Rammensee H, Eklund A, Weissert R, Grunewald J (2009) Autoimmune T cell responses to antigenic peptides presented to bronchoalveolar lavage HLA-DR molecules in sarcoidosis. J Clin Immunol 133:353-363
157. Warren HS (2005) Toll-like receptors. Crit Care Med 33(12):S457-S459
158. Wikén M, Idali F, Al Hayja MA, Grunewald J, Eklund A, Wahlström J (2010) No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2 in bronchoalveolar lavage cells in sarcoidosis. Respir Res 11(1):121-133
159. Williams WJ, Price CD, Pugh A, Dighero M (1977) In vitro (KMIF) Test. Zeitschrift für Erkrankungen der Atmungsorgane 149(2):226-230
160. Wilsher ML, Hallowes M, Birchall NM (1996) Gamma/delta cells in tissue from patients with sarcoidosis. Thorax 51:1123-1126
161. Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC (1977) Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 104:352-361
162. Zaba LC, Smith GP, Sanchez M, Prystowsky SD (2010) Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol 42:32-39
163. Ziegenhagen MW, Müller-Quernheim J (2003) The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 253:18-30
164. Zissel G, Prasse A, Müller-Quernheim J (2007) Sarcoidosis - immunopathogenetic concepts. Semins Respir Crit Care Med 28(1):3-14